New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

News   Aug 15, 2017 | Original story from University of California, San Diego

 
New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

These are muscle cells from a patient with myotonic dystrophy type I, untreated (left) and treated with the RNA-targeting Cas9 system (right). The MBNL1 protein is in green, repetitive RNA in red and the cell’s nucleus in blue. MBNL1 is an important RNA-binding protein and its normal function is disrupted when it binds repetitive RNA. In the treated cells on the right, MBNL1 is released from the repetitive RNA. Credit: UCSD

 
 
 

RELATED ARTICLES

CRISPR Technology Used to Make Stem Cells

News

In a world first, CRISPR genome editing has been used to reprogram skin cells to function as pluripotent stem cells.

READ MORE

Magnetic MicroRNAs Could Help Treat Incontinence

News

An unlikely combination of magnets and MicroRNAs might be a novel treatment for constipation and incontinence patients.

READ MORE

All in a Droplet: Atomic Resolution of ALS Protein Resolved

News

Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE